These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 23231387
1. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma. Chang KW, Chu TH, Gong NR, Chiang WF, Yang CC, Liu CJ, Wu CH, Lin SC. Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387 [Abstract] [Full Text] [Related]
2. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Lin SC, Kao SY, Chang JC, Liu YC, Yu EH, Tseng SH, Liu CJ, Chang KW. Oncotarget; 2016 Sep 20; 7(38):61355-61365. PubMed ID: 27542258 [Abstract] [Full Text] [Related]
3. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC. Oncogene; 2012 May 10; 31(19):2401-11. PubMed ID: 21927029 [Abstract] [Full Text] [Related]
4. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, Lui MT, Lin SC. Oral Oncol; 2013 Jan 10; 49(1):27-33. PubMed ID: 22854067 [Abstract] [Full Text] [Related]
5. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Shin KH, Bae SD, Hong HS, Kim RH, Kang MK, Park NH. Biochem Biophys Res Commun; 2011 Jan 28; 404(4):896-902. PubMed ID: 21167132 [Abstract] [Full Text] [Related]
6. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, Juang JL, Wang HC, Cheng AJ, Lu YC, Wang LH. Cancer Res; 2014 Feb 01; 74(3):751-64. PubMed ID: 24335959 [Abstract] [Full Text] [Related]
7. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J. Cancer Res; 2011 Sep 01; 71(17):5765-78. PubMed ID: 21795477 [Abstract] [Full Text] [Related]
8. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. Oral Oncol; 2010 Mar 01; 46(3):204-8. PubMed ID: 20138800 [Abstract] [Full Text] [Related]
9. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. Yang CJ, Shen WG, Liu CJ, Chen YW, Lu HH, Tsai MM, Lin SC. J Oral Pathol Med; 2011 Aug 01; 40(7):560-6. PubMed ID: 21226887 [Abstract] [Full Text] [Related]
10. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Yan B, Fu Q, Lai L, Tao X, Fei Y, Shen J, Chen Z, Wang Q. Mol Med Rep; 2012 Sep 01; 6(3):675-81. PubMed ID: 22751686 [Abstract] [Full Text] [Related]
12. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor. Zhang B, Li Y, Hou D, Shi Q, Yang S, Li Q. Cell Physiol Biochem; 2017 Sep 01; 42(5):2105-2117. PubMed ID: 28810236 [Abstract] [Full Text] [Related]
13. miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas. Liu CJ, Tsai MM, Tu HF, Lui MT, Cheng HW, Lin SC. Ann Surg Oncol; 2013 Dec 01; 20 Suppl 3():S406-14. PubMed ID: 23138850 [Abstract] [Full Text] [Related]
14. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression. Nagai H, Hasegawa S, Uchida F, Terabe T, Ishibashi Kanno N, Kato K, Yamagata K, Sakai S, Kawashiri S, Sato H, Yanagawa T, Bukawa H. Int J Oncol; 2018 Mar 01; 52(3):841-850. PubMed ID: 29393341 [Abstract] [Full Text] [Related]
15. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF, Jenei V, Robinson CM, Moutasim K, Benn TM, Threadgold SP, Lopes V, Wei W, Thomas GJ, Paterson IC. Oncogene; 2009 Jul 09; 28(27):2524-34. PubMed ID: 19448673 [Abstract] [Full Text] [Related]
16. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis. Okada S, Irié T, Tanaka J, Yasuhara R, Yamamoto G, Isobe T, Hokazono C, Tachikawa T, Kohno Y, Mishima K. J Oral Pathol Med; 2015 Feb 09; 44(2):115-25. PubMed ID: 25060351 [Abstract] [Full Text] [Related]
17. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B. Li L, Ma HQ. Mol Med Rep; 2015 Aug 09; 12(2):3156-62. PubMed ID: 25955794 [Abstract] [Full Text] [Related]
18. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma. Yamada S, Yanamoto S, Yoshida H, Yoshitomi I, Kawasaki G, Mizuno A, Nemoto TK. Int J Oral Maxillofac Surg; 2010 Jan 09; 39(1):61-7. PubMed ID: 19913389 [Abstract] [Full Text] [Related]
19. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma. Liu SL, Zhong SS, Ye DX, Chen WT, Zhang ZY, Deng J. J Oral Pathol Med; 2013 Nov 09; 42(10):761-8. PubMed ID: 23651229 [Abstract] [Full Text] [Related]
20. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC, Chen YW. Mol Cancer; 2014 Jan 10; 13():6. PubMed ID: 24410957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]